Citigroup’s DermTech, Inc. Common Stock DMTK Stock Holding History

Citigroup’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$4	–	5785
2023 Q1	$4	Hold	1	–	–	﹤0.01%	5431
2022 Q4	$2	Sell	1 -9,803	-100%	-$26.1K	﹤0.01%	5745
2022 Q3	$39K	Sell	9,804 -985	-9%	-$6.06K	﹤0.01%	4501
2022 Q2	$60K	Sell	10,789 -39,207	-78%	-$321K	﹤0.01%	4462
2022 Q1	$734K	Sell	49,996 -141,492	-74%	-$1.89M	﹤0.01%	3219
2021 Q4	$3.03M	Buy	191,488 +118,419	+162%	+$2.84M	﹤0.01%	2258
2021 Q3	$2.35M	Sell	73,069 -41,480	-36%	-$1.46M	﹤0.01%	2408
2021 Q2	$4.76M	Buy	114,549 +36,334	+46%	+$1.49M	﹤0.01%	1932
2021 Q1	$3.97M	Buy	78,215 +76,655	+4,914%	+$4.01M	﹤0.01%	1961
2020 Q4	$51K	Buy	1,560 +1,171	+301%	+$16.6K	﹤0.01%	6033
2020 Q3	$5K	Sell	389 -700	-64%	-$8.11K	﹤0.01%	7056
2020 Q2	$14K	Buy	1,089 +726	+200%	+$9.46K	﹤0.01%	6877
2020 Q1	$4K	Buy	+363	New	+$4.46K	﹤0.01%	7337

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citigroup's DMTK Position: Q2 2023 in Review

Citigroup sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 1 share — an estimated $4 sold.

Citigroup first reported a position in DMTK in Q1 2020 and held it in 13 quarters. The position peaked at $4.76M in Q2 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Citigroup reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Citigroup sold 1 DermTech, Inc. Common Stock share in Q2 2023, an estimated $4.
Citigroup first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
Citigroup's DermTech, Inc. Common Stock position peaked at $4.76M in Q2 2021.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.